| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.04 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |